SCHEMBL25354268

SCHEMBL25354268

N[C@H](CNC(=O)C1CCN(CC(=O)O)CC1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 1/20 0.47
ITGA2B P08514 1/20 0.47
FOLH1 Q04609 3/20 0.38
HSD17B10 Q99714 1/20 0.38
GAA P10253 2/20 0.36
GNAI3 P08754 1/20 0.36
GNAO1 P09471 1/20 0.36
GNAI1 P63096 1/20 0.36
GSK3B P49841 1/20 0.36
DYRK1A Q13627 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 1/20 0.36
ATM Q13315 1/20 0.36
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
OPRM1 P35372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26009590 1.00 ITGB3 (0.47) ITGB3ITGA2BFOLH1HSD17B10GAA
SCHEMBL25354278 1.00 ITGB3 (0.47) ITGB3ITGA2BFOLH1HSD17B10GAA
SCHEMBL26008158 0.89 ITGB3 (0.46) ITGB3ITGA2BHSD17B10GAAGNAI3
SCHEMBL26008334 0.89 ALDH1A1 (0.38) ITGB3ITGA2BHSD17B10GAAGNAI3
SCHEMBL25356825 0.83 FOLH1 (0.51) ITGB3ITGA2BFOLH1HSD17B10GNAI3
SCHEMBL26009827 0.83 FOLH1 (0.51) ITGB3ITGA2BFOLH1HSD17B10GNAI3
SCHEMBL1769506 0.82 ITGB3 (0.50) ITGB3ITGA2BKMT2A
SCHEMBL1769508 0.82 ITGB3 (0.50) ITGB3ITGA2BKMT2A
SCHEMBL25357386 0.80 FOLH1 (0.41) ITGB3ITGA2BFOLH1GAAGNAI3
SCHEMBL25357374 0.80 FOLH1 (0.41) ITGB3ITGA2BFOLH1GAAGNAI3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US claimed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP ITGB3 4109/4885ITGA2B 3548/4885FOLH1 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.